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ABSTRACTSwiring. We found no correlation between glove perforation and sternal
wound infection.
0153: DOES EXPLORATIVE THORACOTOMY FOR NON-SMALL CELL LUNG
CANCER (NSCLC) ADVERSELY AFFECT PATIENTS’ OUTCOME
POSTOPERATIVELY?
James Rigby, Aiman Alzetani, Adam Lea, Shilajit Ghosh. University Hospital
of North Staffordshire, Stoke-on-Trent, UK
Aims: To determine our incidence of explorative thoracotomy for NSCLC
and its inﬂuence on further management of patients & their survival.
Methods: Retrospective review of patients referred for lung cancer surgery
over 2.5 years. Clinical data were collected on radiological/pathological
staging and post-operative management including survival status.
Results: Between January 2008-August 2011, 418 patients underwent
thoracotomy for primary lung cancer, of which 27 patients (6%) had
inoperable disease. Of the inoperable cases, 4 (15%) had a pre-explorative
mediastinoscopy and 22 (81%) were investigated with PET studies.
Sixteen patients (59%) had radiological-advanced stage (IIIA-). Inoper-
ability was due to stage migration, N2 disease, tumour invasion or poor
physiological status intra-operatively.
Subsequent treatments included adjuvant (chemotherapy/ radiotherapy
/combined) in 16 patients (59%) of which 12 (75%) are still alive with an
average length of survival of 9 months.
Conclusion: Our incidence of explorative thoracotomy is well within those
reported in the literature. Over half of patients were still suitable for radical
adjuvant treatment and 44% survived for an average 9 months post-
surgery.
Surgery should not be denied for advanced NSCLC to avoid depriving
patients the beneﬁt of curative resection and if resection cannot be ach-
ieved then some patients are suitable for adjuvant treatments.
0308: THE USE OF HOMOGRAFTS IN THE OPERATIVE MANAGEMENT OF
INFECTIVE ENDOCARDITIS HAS LOWER SHORT AND MEDIUM-TERM
MORTALITY AND IMPROVED OVERALL OUTCOME COMPARED TO
PROSTHETIC VALVES
Abderahman Kamaledeen 1, Rizwan Q. Attia 2, James C.
Roxburgh 2, Christopher P. Young 2, Christopher I. Blauth 2. 1King's
College London, London, UK; 2Department of Cardiothoracic Surgery, St
Thomas' Hospital, London, UK
Aim: Infective endocarditis remains a challenging clinical entity, particu-
larly with changing causative organisms. We aim to characterize the
operative management, microbiology, operative mortality and long-term
survival in a contemporary cohort of patients having surgery for IE.
Methods: We reviewed the records of 125 consecutive patients who had
surgery for IE over ﬁve years (2006-2011), at a large tertiary cardiovascular
centre. The valve prosthesis, causative organism, in-hospital morality,
long-term survival and need for repeat surgery were examined.
Results: Cumulative Kaplan-Meier survival was 86.8% at one-year and
67.8% at ﬁve years. 101/125(80.8%) patients had isolated valve surgery, 13/
125(13.6%) two valves and 7/125(5.6%) three valves. Of the aortic valve IE,
24/66(36.3%) patients had aortic homograft (LES 44.7%), 33/66(50%) had
tissue valve (LES47.7%) and 9/66(13.6%) mechanical prosthesis (LES 23.3%).
The use of Homograft as a valve substitute was more common in patients
with annular involvement and intracardiac abscesses. In-hospital
mortality for homograft was 4.5% vs. 8% for prosthetic valve p0.01. There
were no re-infections in the homograft group vs. 4.5% for prosthetic valve
p0.001.
Conclusion: In patients having operation for infective endocarditis,
homograft valve replacement provided excellent short and medium-term
outcomes with superior survival and freedom from re-intervention
compared with prosthetic valve replacement
0380: THE ROLE OF SURGICAL LUNG BIOPSY IN THE MANAGEMENT OF
UNDEFINED PARENCHYMAL LUNG DISEASE
Vivienne Blackhall, Felice Granato, Katrina Knight, Bernadette Quinn, Ali
Jilaihaiwi, Alan Kirk, Mohammed Asif. Golden Jubilee National Hospital,
Glasgow, UK
Aim: To examine whether surgical lung biopsy (SLB) is worthwhile in the
diagnosis of undeﬁned parenchymal lung disease (UPLD).Methods: 113 patients over a two year period at a single institution
underwent SLB for UPLD. Patient demographics, pre-operative diagnosis
and treatment, surgical approach, number and site of biopsies, complica-
tions, length of postoperative stay and postoperative diagnosis and treat-
ment were examined.
Results: Fifty six patients were female and 57 were male. The median age
was 59 years. Following biopsy, 27% of patients received no clear patho-
logical diagnosis and 73% received a speciﬁc diagnosis. Of all patients, 42%
had a change in their treatment following the procedure. We observed 5
(4%) perioperative deaths, 7 major complications (6%) and 8 minor
complications (8%). The median hospital stay was 4 days.
Conclusions: Surgical lung biopsy is a relatively safe procedure. Although
it provides an accurate diagnosis for many patients, SLB can be inconclu-
sive and can fail to provide a consistent change in patient management. It
can be associated with a prolonged post-operative stay, resulting in an
increased cost to the NHS. SLB should therefore be performed in a select
group of patients with UPLD after discussion at a respiratory multidisci-
plinary team meeting.
0513: WHAT'S THE ROLE OF VENTRICULAR ENDOCARDIAL
RECONSTRUCTION SURGERY IN 2011? A SINGLE CENTRE 7 YEAR
EXPERIENCE
Rizwan Attia, Hannah Fleming, John Chambers, Fikrat Shabbo. Guys and
Saint Thomas', London, UK
Aim: Surgical ventricular restoration in patients with coronary artery
disease, post infarction left ventricular aneurysm or ischemic dilated
cardiomyopathy is a viable treatment option,yet conﬂicting data currently
exists. We evaluated the 7-year clinical experience of this procedure in our
institution.
Methods: From 2003 to 2010, surgical ventricular restoration was per-
formed in 86 patients (M2.3:1F), mean age 64.5 years. All patients pre-
sented with angina, heart failure and/or ventricular tachycardia.
Post-infarction left ventricular aneurysm was present in all patients and
ischemic dilated cardiomyopathy with a large akinetic left ventricle in
11.6%. The preoperative left ventricular ejection fraction was 33.110 %.
Multi-vessel disease was present in 93% patients.
Results: All patients underwent endoventricular or circular patch repair.
94% had concomitant coronary revascularisation, median of 2 grafts and 5%
had mitral valve repair. Intra-aortic balloon pump was placed pre-opera-
tively in 18.6% while 16.2% needed inotropic support for more than 24h.
Postoperative stroke occurred in 1 patient. In-hospital mortality was 4.6%.
All cause cardiovascular mortality at ﬁve years was 8.1%. Mean follow-up in
operative survivors was 4.42.8years. Actuarial survival at 1,2 and 5 years
was 90.6%, 87.9% and 79.1%.
Conclusions: Early and long-term results are good in terms of survival and
better when compared to ventricular resynchronisation therapy and
medical management.
0567: A FIVE YEAR AUDIT STUDY ON DEEP STERNAL WOUND
INFECTIONS AND ASSOCIATED DEHISCENCE POST MEDIAN
STERNOTOMY: AN ANALYSIS OF PATIENT OUTCOME, RISK FACTORS
AND A PROPOSED MANAGEMENT STRATEGY
Kenneth Porter 1, Rujuta Roplekar 2, Pari Mohanna 1. 1 St Thomas' Hospital,
London, UK; 2King's College Hospital, London, UK
Aims: To audit risk factors, outcome and management of patients who
developed post median sternotomy wound infections and associated
dehiscence.
Methods: In a ﬁve year retrospective study 6335 consecutive patients who
underwent median sternotomies for coronary artery bypass grafts and
aortic valve replacements were examined.
Results: There were 166 sternal wound infections (2.6%). 48 patients
(0.76%) underwent treatments such as vacuum therapy and debridements
for sternal dehiscence. Increased age, BMI, a lower ejection fraction and
diabetes were risk factors for developing sternal wound infections
requiring more radical treatments.
18 patients required sternal reconstruction in the form of a ﬂap and on
average were seen by plastic surgeons 13 days after the onset of dehis-
cence. In the reconstruction group each patient received on average 27
days of vacuum therapy and 3 debridements.
